10 SAMHSA-listed treatment centers across 3 cities in Alaska. Free, confidential help available 24/7.
Peaceful Anchorage Treatment Center provides a steady bridge for those seeking recovery in Anchorage...
Tidewater Fairbanks Recovery Institute provides a warm harbor for those seeking recovery in Fairbank...
Bayview Juneau Wellness Institute provides a quiet strength for those seeking recovery in Juneau, Al...
Summit Anchorage Rehab Center provides a ocean of hope for those seeking recovery in Anchorage, Alas...
Clearwater Fairbanks Recovery Clinic provides a safe haven for those seeking recovery in Fairbanks, ...
Bridge Juneau Treatment Center provides a bridge to wellness for those seeking recovery in Juneau, A...
Shores Anchorage Recovery Institute provides a harbor of hope for those seeking recovery in Anchorag...
Serenity Fairbanks Wellness Institute provides a tranquil recovery for those seeking recovery in Fai...
Beacon Juneau Rehab Center provides a peaceful passage for those seeking recovery in Juneau, Alaska....
Calm Waters Anchorage Recovery Clinic provides a calm waters for those seeking recovery in Anchorage...
Alaska ranks at 32.6 drug overdose deaths per 100,000 residents per the most recent CDC WONDER data — at the national rate of 32.6/100k. Of the verified treatment facilities listed here, roughly 70-80% offer outpatient programs, 20-25% provide medical detox or residential rehabilitation, and a smaller subset addresses dual-diagnosis cases.
Listings are sourced from the federal SAMHSA treatment locator and updated quarterly against state licensing-board records. No pay-for-placement.
Under the federal Mental Health Parity and Addiction Equity Act, most insurance plans in Alaska must cover substance-use treatment at parity with physical-health benefits.
Aetna · Anthem · Blue Cross Blue Shield · Cigna · Humana · Kaiser Permanente · UnitedHealthcare · Medicare · Alaska Medicaid · Tricare (military) · VA Community Care
In Alaska, Medicaid is administered as Alaska Medicaid. State-licensed facilities are typically required to accept it for substance-use treatment. Verify eligibility at medicaid.gov.
Population-specific programming is not marketing fluff — it is supported by retention data. Alaska facilities with targeted tracks for women, veterans, adolescents, and LGBTQ+ patients see materially better completion rates than mixed programming for those groups.
Trauma-informed care, pregnancy-aware medical management, parenting groups.
Emotion-regulation focus, anger management, fatherhood support, identity processing.
School integration, family therapy required, lower-intensity longer-duration models.
Combat-trauma-aware programming, VA Community Care eligibility, military culture competence.
Identity-affirming therapy, anti-discrimination policies, family-of-choice integration.
Psychiatry on staff, integrated treatment of depression/anxiety/PTSD/bipolar alongside substance use.
Nursing/physician recovery monitoring, confidential reporting, return-to-practice protocols.
Late-onset alcohol-use disorder, polypharmacy concerns, age-appropriate group composition.
Whether you choose a non-profit IOP in your hometown or a private residential program elsewhere in Alaska, hours-per-day, group-therapy density, and medical-management cadence follow industry-standard patterns. The card grid below outlines the standard modalities.
A short-term, goal-focused therapy. CBT for addiction works on identifying high-risk situations and rehearsing alternative responses before they occur in the wild.
Used to build internal motivation during the first weeks. MI evokes the patient's own change-talk and amplifies it through reflective listening.
Medication-Assisted Treatment combines an FDA-approved medication with counseling. For opioid-use disorder, buprenorphine and methadone are the gold standard.
A skills-acquisition therapy. Patients learn distress-tolerance and emotion-regulation techniques explicitly, in group format.
About half of people entering addiction treatment also meet criteria for a trauma-related diagnosis. Specific therapies (EMDR, CPT, Seeking Safety) address both.
Twelve-Step facilitation is an evidence-based clinical approach, distinct from AA/NA membership. Facility staff use it to introduce mutual-support concepts.
Whether you enter a state-funded outpatient clinic or a private residential facility in Alaska, the admission workflow is recognizable: counselor call, benefits run, ASAM-level assessment, prep, and intake day. Total elapsed time: usually 1–7 days; faster if urgent.
| Level | Duration | OOP (insured) | Best fit |
|---|---|---|---|
| Medical detox | 3–7 days | $0–$3,000 | Severe alcohol/opioid withdrawal |
| Residential / Inpatient | 28–90 days | $0–$10,000 | Moderate-to-severe addiction, 24/7 structure needed |
| Partial Hospitalization (PHP) | 2–6 weeks | $0–$5,000 | 20+ hrs/wk structured care |
| Intensive Outpatient (IOP) | 8–12 weeks | $0–$2,500 | 9–19 hrs/wk, fits work/school |
| Standard Outpatient | 3–12+ months | $0–$1,500 | Aftercare or mild dependence |
Whether you are the person seeking treatment or the family member supporting them, the recovery process benefits from both sides being informed and connected. Most Alaska facilities now include structured family programming as part of standard care.
Without insurance, the cost of Alaska treatment can seem prohibitive, but every uninsured-pathway in the state has been used by real people. The trick is matching pathway to your circumstance: income, veteran status, court involvement, religious openness.
Treatment alone does not produce long-term sobriety in Alaska; structured aftercare during the 12 months after discharge does most of the work. Plan for it before treatment ends, not after.
Continuing outpatient therapy is the bridge from intensive treatment to long-term sobriety. Most insurance plans cover at least 6 months of weekly sessions.
Sober living homes range from highly structured residences to lightly-supervised group homes. In Alaska, NARR-certified ones meet a national standard; uncertified ones vary widely.
Daily meetings available in most Alaska cities. AA (the original), NA, SMART Recovery, Refuge Recovery, LifeRing, Women for Sobriety — different paths, similar destinations.
For opioid-use disorder, MAT (buprenorphine, methadone, or extended-release naltrexone) should continue for as long as benefit persists — often indefinitely.
Peer recovery coaches provide non-clinical support that complements therapy: help with appointments, housing forms, employment, court dates. Often free.
Free naloxone kits at most Alaska pharmacies under standing orders. Family training is mandatory — kits in a drawer no one knows how to use don't prevent overdoses.
The first 90 days post-discharge are highest-risk. Daily community contact, scheduled therapy/coaching, MAT continuity, written relapse-response plan.
All statistics and policy claims sourced from federal-government and peer-reviewed agencies. Last verified May 2026.
The Alaska treatment providers above differ meaningfully in programming intensity, clinical staffing models, and population fit. Use the profiles below to narrow your shortlist before contacting admissions.
Family involvement at Peaceful Anchorage Treatment Center is structured, not optional. The Anchorage facility runs a family-education program covering the disease model of addiction, codependency dynamics, communication patterns that enable versus support recovery, and the realistic shape of post-treatment life. Alaska families participate via in-person sessions when geography permits and structured video sessions otherwise. Discharge planning explicitly addresses the family system the patient is returning to — boundary conversations, household alcohol policy, naloxone training where indicated — not just the patient in isolation.
Clinical staffing at the Fairbanks location includes licensed alcohol and drug counselors, master's-level therapists, registered nurses on rotation, and a consulting physician experienced in addiction medicine. Tidewater Fairbanks Recovery Institute maintains the Alaska-required staffing ratios for residential addiction treatment and follows ASAM-aligned clinical practice guidelines. Group therapy is co-facilitated when census permits, and individual sessions occur a minimum of twice weekly during residential phases. Family therapy is scheduled weekly once the patient has stabilized and consents to family involvement, typically by day 10 of admission.
Many patients arriving at Bayview Juneau Wellness Institute present with co-occurring mental-health conditions — anxiety, depression, PTSD, bipolar, or attention disorders — that interact with the addiction in ways that demand integrated treatment rather than sequential. The Juneau clinical team is built for dual-diagnosis cases: licensed mental-health professionals alongside addiction specialists, psychiatric medication management when indicated, and treatment plans that address both conditions simultaneously. Alaska adults who've cycled through detox-only programs without lasting results often see better outcomes with this integrated approach.
Summit Anchorage Rehab Center operates as a state-licensed addiction treatment provider in Anchorage, Alaska, credentialed to deliver clinically supervised care across the standard ASAM continuum. Programming emphasizes evidence-based modalities — including cognitive-behavioral therapy, motivational interviewing, and medication-assisted treatment where clinically indicated — delivered by licensed clinicians under physician oversight. Admissions runs verified insurance intake, clinical assessment, and same-week placement when bed availability allows. Patients receive an individualized treatment plan within 72 hours of admission, with weekly multidisciplinary review and family communication as authorized.
Clearwater Fairbanks Recovery Clinic serves adults across the spectrum of substance-use severity — from working professionals seeking discrete treatment for early-stage alcohol dependence to patients with decades of opioid use, prior treatment episodes, and complex medical histories. The Fairbanks program adapts intensity and approach to the individual: some patients need primarily medical stabilization and connection to MAT, others need intensive psychotherapy for unprocessed trauma, others need both. Alaska admissions screens for fit before admission rather than after — patients whose needs fall outside the program's scope are referred to appropriate alternatives.
Levels of care at Bridge Juneau Treatment Center span medically supervised detox, residential inpatient, partial hospitalization, and intensive outpatient — letting clinicians match intensity to ASAM criteria as recovery progresses. The Juneau facility maintains 24/7 nursing during detox and inpatient phases, with medical director consultation available for complex withdrawal presentations. Step-down decisions follow standardized clinical criteria rather than calendar dates, so Alaska residents complete higher-intensity care only as long as it's clinically warranted, then transition to less restrictive settings with continuity of therapist and treatment plan.
A typical week at Serenity Fairbanks Wellness Institute blends process groups, psychoeducation, individual therapy, and recovery-skill workshops — structured to address both substance use and the co-occurring patterns that fuel relapse. The Fairbanks program incorporates trauma-informed approaches, twelve-step facilitation as one (not the only) recovery pathway, and experiential modalities including mindfulness and physical wellness. Alaska patients receive a relapse-prevention plan in the final week of residential care, with named triggers, named coping skills, and named support contacts — not a generic handout.
Beacon Juneau Rehab Center operates as a state-licensed addiction treatment provider in Juneau, Alaska, credentialed to deliver clinically supervised care across the standard ASAM continuum. Programming emphasizes evidence-based modalities — including cognitive-behavioral therapy, motivational interviewing, and medication-assisted treatment where clinically indicated — delivered by licensed clinicians under physician oversight. Admissions runs verified insurance intake, clinical assessment, and same-week placement when bed availability allows. Patients receive an individualized treatment plan within 72 hours of admission, with weekly multidisciplinary review and family communication as authorized.
Outcome tracking at Calm Waters Anchorage Recovery Clinic extends beyond completion rates: the Anchorage facility follows up at 30, 90, and 180 days post-discharge to measure abstinence, quality of life, employment stability, and re-engagement with substance use. Aggregate outcome data is reviewed quarterly by clinical leadership and used to refine programming — what's working with which presentations gets reinforced, what's not gets revised. Alaska families considering this provider can request outcome summaries during the admissions consultation; transparency about real-world results is a marker of a clinically serious program.
This section covers state-level context for addiction treatment in Alaska: how the clinical continuum is structured, what federal resources are available, how insurance works in practice, and what evidence-based approaches apply to different substances and populations. The goal is to equip you to navigate Alaska treatment options effectively, whether you're researching for yourself or a family member.
Alaska treatment providers operate within the ASAM Criteria framework, which standardized placement decisions across the field. Withdrawal severity is the first screening factor — patients showing or at risk for moderate-to-severe alcohol or benzodiazepine withdrawal typically require medically managed detox before transitioning to lower-intensity care. Opioid use patients face a different decision tree: detox is rarely effective alone for opioid use disorder, and most evidence-based pathways involve medication-assisted treatment (MAT) initiated during stabilization.
Crisis resources for Alaska residents in immediate need: dial 988 (Suicide & Crisis Lifeline, available 24/7 in English, Spanish, and ASL); text HOME to 741741 (Crisis Text Line); call SAMHSA's National Helpline at 1-800-662-HELP for treatment-referral information; visit any hospital emergency department for medical emergencies including overdose, severe withdrawal, or suicidal ideation. Carry naloxone if you or anyone in your household uses opioids — most Alaska pharmacies dispense it without prescription under standing orders.
Federal data on Alaska substance use comes from multiple sources: CDC WONDER provides drug-overdose mortality statistics; the National Survey on Drug Use and Health (NSDUH) tracks treatment access and substance-use prevalence; SAMHSA's TEDS (Treatment Episode Data Set) captures admissions and discharges; and the State Unintentional Drug Overdose Reporting System (SUDORS) tracks overdose deaths in detail. These datasets are public and inform both treatment policy and patient resource navigation.
Co-occurring medical conditions require coordinated management for Alaska addiction patients. Common comorbidities: hepatitis C (curable with direct-acting antivirals); HIV (manageable with antiretroviral therapy); endocarditis (in IV drug users); chronic pain (requires non-opioid pain management strategy); diabetes; hypertension; chronic respiratory conditions. Integrated primary-care + addiction-treatment models address the whole patient; siloed care often results in poor outcomes for both conditions.
Cost expectations for Alaska residential addiction treatment range broadly: 30-day residential at facilities accepting most commercial insurance often runs $10,000-$30,000 before insurance pays; premium or specialty facilities can run $30,000-$70,000+. With in-network insurance, patient out-of-pocket typically lands at the plan's annual out-of-pocket maximum, often $7,000-$10,000 for an individual. Medicaid-covered treatment generally has no direct patient cost beyond modest copays where applicable.
Substance-specific treatment in Alaska differs meaningfully by drug class. Alcohol use disorder treatment typically involves medically supervised detox (alcohol withdrawal can be fatal in severe cases), behavioral therapy, and medication options including naltrexone (blocks reward), acamprosate (reduces craving), and disulfuram (creates negative reaction to drinking). Opioid use disorder treatment is medication-forward: buprenorphine or methadone reduce overdose mortality by 50%+ in clinical trials. Stimulant use disorder (cocaine, methamphetamine) lacks FDA-approved medications, so behavioral interventions (contingency management, cognitive-behavioral therapy) carry the clinical load.